Syra Health (NASDAQ:SYRA – Get Free Report) released its earnings results on Tuesday. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.11, reports. The company had revenue of $2.56 million during the quarter, compared to the consensus estimate of $2.20 million. Syra Health had a negative return on equity of 131.94% and a negative net margin of 54.90%.
Syra Health Price Performance
Shares of NASDAQ SYRA traded up $0.01 during midday trading on Wednesday, hitting $0.94. The company’s stock had a trading volume of 23,739 shares, compared to its average volume of 41,524. The firm has a market capitalization of $12.99 million, a price-to-earnings ratio of -1.44 and a beta of 2.91. The business’s fifty day simple moving average is $0.87 and its two-hundred day simple moving average is $0.53. Syra Health has a 1 year low of $0.06 and a 1 year high of $1.15.
About Syra Health
Syra Health Corp. is a healthcare technology and services company focused on improving access, delivery and outcomes across the U.S. healthcare system. The company develops solutions for behavioral and mental health, population health management, healthcare education and workforce needs.
Its offerings are designed to support healthcare providers, government agencies, employers and other organizations. Syra Health combines technology, data and professional services to assist with areas such as care coordination, health education, clinical workforce development, behavioral health programs and population health initiatives.
Based in Carmel, Indiana, Syra Health was established in the early 2020s and serves clients in the United States.
Further Reading
- Five stocks we like better than Syra Health
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
- Washington Made a $2 Billion Quantum Bet, But Can Either ETF Match It?
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.
